Back to Journals » Breast Cancer: Targets and Therapy » Volume 9

Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib

Total article views   Abstract views HTML views PDF downloads Totals
5,652 Dovepress* 3,669 1,095+ 892 4,764
PubMed Central* 0 888 455 888
Totals 3,669 1,983 1,347 5,652
*Since 6 December 2017
+Since July 2016

View citations on PubMed Central and Google Scholar